Education and training at the University of Hong Kong, Karolinska (Stockholm) and Harvard (Boston)
Taught as academic professor for 18 years in the US, HK and Singapore
Published >200 papers including NEJM, Cell, Nature Medicine, Nature Genetics
Identified and patented CDH17 at HKU (Global License Arbele)
In 2011, moved to drug industry at senior leader position in Roche China and senior director in Johnson & Johnson Medical China to lead drug discovery and development programs in oncology, immunology and hepatitis
Former honorary professorship at leading institutions in HK, China and Asia; visiting associate professor at Harvard; established strong scientific, clinical and industrial networks globally
Former VP Clinical Development of Sanofi in Asia Pacific
>20 years drug development in big pharma (Genentech, Roche, BMS and Sanofi)
Successful track records in FDA drug filing from FIH to NDA (with 5 BLA filed)
Board certified internal medicine, allergy & immunology
Harvard, UCSF, VCU, Chicago, Tokyo University
Previously executive Deputy GM, Citic Bank
Senior positions in Development Bank of Singapore (DBS), Standard Chartered, ANZ, ING and Citi
Bachelor of Economics and Master of Applied Finance
More than 10 years experience in drug development with multinational pharmaceutical companies and biotech startups
Target discovery, lead identification, optimization, Investigational New Drug (IND)-enabling studies and clinical trial designs
PhD (University of Hong Kong)
HKU Law Graduate
15 years as a lawyer and legal counsel
Specialized practice in legal business, with rich M&A experience in technology & energy fields
Specialized in public administration
20+ year experience in health care and hospital authority
Co-founding Tiberias Ltd, a HK biotech focusing on oncology drug development
Education and training at the University of Hong Kong, Karolinska (Stockholm) and Harvard (Boston)
Taught as academic professor for 18 years in the US, HK and Singapore
Published >200 papers including NEJM, Cell, Nature Medicine, Nature Genetics
Identified and patented CDH17 at HKU (Global License Arbele)
In 2011, moved to drug industry at senior leader position in Roche China and senior director in Johnson & Johnson Medical China to lead drug discovery and development programs in oncology, immunology and hepatitis
Former honorary professorship at leading institutions in HK, China and Asia; visiting associate professor at Harvard; established strong scientific, clinical and industrial networks globally
Former VP Clinical Development of Sanofi in Asia Pacific
>20 years drug development in big pharma (Genentech, Roche, BMS and Sanofi)
Successful track records in FDA drug filing from FIH to NDA (with 5 BLA filed)
Board certified internal medicine, allergy & immunology
Harvard, UCSF, VCU, Chicago, Tokyo University